Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab in non-infectious active cryoglobulinemia vasculitis
2020-004519-29Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cryoglobulinaemia comparing Belimumab with Placebo (2 arms). Started Jan 2021; status: active.
02
Drugs
belimumab
03
Conditions
cryoglobulinaemia
Beyond the preview
Go deeper on 2020-004519-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004519-29.